FUL.L Regulatory News (FUL)

20 Dec 2007 17:35

Fulcrum Pharma PLC20 December 2007 FULCRUM PHARMA PLC ("the Company") Result of AGM Fulcrum Pharma plc (AIM: FUL), the drug development and regulatory servicescompany, announces that, at today's annual general meeting, all resolutions werepassed. For further information, please contact: Fulcrum Pharma PLCJon Court, Chief Executive Tel: 0870 710 7152 Seymour PierceJonathan Wright Tel: 0207 107 9000 About Fulcrum Pharma plc Fulcrum Pharma plc is a drug development and regulatory services business thatprovides global expertise to achieve drug development and regulatory approvalmilestones. Fulcrum Pharma offers immediate access to a highly credible,integrated development team that provides strategic and operational leadershiprequired to ensure that new drugs move smoothly from discovery research toproduct approval Fulcrum Pharma is listed on the AIM Market of the London Stock Exchange havingsuccessfully floated in March 2000. This information is provided by RNS The company news service from the London Stock Exchange